These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28325750)

  • 1. Molecular Pathways: Evaluating the Potential for B7-H4 as an Immunoregulatory Target.
    MacGregor HL; Ohashi PS
    Clin Cancer Res; 2017 Jun; 23(12):2934-2941. PubMed ID: 28325750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a novel anti-B7-H4 antibody enhances anti-tumor immune response of human T cells.
    Miao G; Sun X
    Biomed Pharmacother; 2021 Sep; 141():111913. PubMed ID: 34328096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host B7-H4 regulates antitumor T cell responses through inhibition of myeloid-derived suppressor cells in a 4T1 tumor transplantation model.
    Leung J; Suh WK
    J Immunol; 2013 Jun; 190(12):6651-61. PubMed ID: 23686485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could B7-H4 serve as a target to activate anti-cancer immunity?
    Wang L; Heng X; Lu Y; Cai Z; Yi Q; Che F
    Int Immunopharmacol; 2016 Sep; 38():97-103. PubMed ID: 27258187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses.
    Dangaj D; Lanitis E; Zhao A; Joshi S; Cheng Y; Sandaltzopoulos R; Ra HJ; Danet-Desnoyers G; Powell DJ; Scholler N
    Cancer Res; 2013 Aug; 73(15):4820-9. PubMed ID: 23722540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunity.
    Rahbar R; Lin A; Ghazarian M; Yau HL; Paramathas S; Lang PA; Schildknecht A; Elford AR; Garcia-Batres C; Martin B; Berman HK; Leong WL; McCready DR; Reedijk M; Done SJ; Miller N; Youngson B; Suh WK; Mak TW; Ohashi PS
    Cancer Immunol Res; 2015 Feb; 3(2):184-95. PubMed ID: 25527357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy.
    Smith JB; Lanitis E; Dangaj D; Buza E; Poussin M; Stashwick C; Scholler N; Powell DJ
    Mol Ther; 2016 Nov; 24(11):1987-1999. PubMed ID: 27439899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity.
    Sica GL; Choi IH; Zhu G; Tamada K; Wang SD; Tamura H; Chapoval AI; Flies DB; Bajorath J; Chen L
    Immunity; 2003 Jun; 18(6):849-61. PubMed ID: 12818165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential targeting of B7-H4 for the treatment of cancer.
    Podojil JR; Miller SD
    Immunol Rev; 2017 Mar; 276(1):40-51. PubMed ID: 28258701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unstable B7-H4 cell surface expression and T-cell redirection as a means of cancer therapy.
    Iizuka A; Kondou R; Nonomura C; Ashizawa T; Ohshima K; Kusuhara M; Isaka M; Ohde Y; Yamaguchi K; Akiyama Y
    Oncol Rep; 2016 Nov; 36(5):2625-2632. PubMed ID: 27632942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7-H4 as a potential target for immunotherapy for gynecologic cancers: a closer look.
    Smith JB; Stashwick C; Powell DJ
    Gynecol Oncol; 2014 Jul; 134(1):181-189. PubMed ID: 24657487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
    Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
    Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of co-stimulatory molecule B7-H4 in patients suffering from rheumatoid arthritis.
    Chen L; Lu Y; Wang F; Zhou M; Chu Y; Ding W; Liu C; Xie J; Wu C; Jiang J
    Immunol Lett; 2013; 154(1-2):25-30. PubMed ID: 23973734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic Suppression of B7-H4 Glycosylation Restores Antitumor Immunity in Immune-Cold Breast Cancers.
    Song X; Zhou Z; Li H; Xue Y; Lu X; Bahar I; Kepp O; Hung MC; Kroemer G; Wan Y
    Cancer Discov; 2020 Dec; 10(12):1872-1893. PubMed ID: 32938586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of immune regulatory molecules B7-H4 and PD-L1 in low and high grade endometrial tumors.
    Bregar A; Deshpande A; Grange C; Zi T; Stall J; Hirsch H; Reeves J; Sathyanarayanan S; Growdon WB; Rueda BR
    Gynecol Oncol; 2017 Jun; 145(3):446-452. PubMed ID: 28347512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7-H4, a promising target for immunotherapy.
    Wang JY; Wang WP
    Cell Immunol; 2020 Jan; 347():104008. PubMed ID: 31733822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7-H4(B7x)-Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients.
    Yao Y; Ye H; Qi Z; Mo L; Yue Q; Baral A; Hoon DSB; Vera JC; Heiss JD; Chen CC; Zhang J; Jin K; Wang Y; Zang X; Mao Y; Zhou L
    Clin Cancer Res; 2016 Jun; 22(11):2778-2790. PubMed ID: 27001312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation.
    Wang X; Hao J; Metzger DL; Ao Z; Chen L; Ou D; Verchere CB; Mui A; Warnock GL
    PLoS One; 2012; 7(1):e28232. PubMed ID: 22238573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and Validation of Anti-B7-H4 scFvs from an Ovarian Cancer scFv Yeast-Display Library.
    Dangaj D; Scholler N
    Methods Mol Biol; 2015; 1319():37-49. PubMed ID: 26060068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus.
    Zhang L; Wu H; Lu D; Li G; Sun C; Song H; Li J; Zhai T; Huang L; Hou C; Wang W; Zhou B; Chen S; Lu B; Zhang X
    Oncogene; 2013 Nov; 32(46):5347-58. PubMed ID: 23318460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.